Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06349863

Dutch Cholecystitis Snapshot Study

Variation in Cholecystitis Treatment and Outcome in the Netherlands; a Nation-wide Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
St. Antonius Hospital · Academic / Other
Sex
All
Age
18 Years – 120 Years
Healthy volunteers
Not accepted

Summary

Background: Cholecystitis is treated by in various types of hospitals by different specialists, and treatment strategy is influenced by logistical and medical reasons and personal preference. This may significantly impact hospital stay and other outcomes. Purpose: To determine the variation in treatment of cholecystitis in the Netherlands and its impact on outcome. Methods: Nation-wide cohort study of all patients diagnosed and treated for cholecystitis during a 6 month period. The primary outcome will be the proportion of patients with an acute cholecystitis in which the guideline is followed. This group will be compared to those in which the guideline is not followed, focussing on total hospital stay and complications. Secondary aims are to determine: factors related to guideline compliance; the best method of cystic duct closure; the best treatment strategy for a \>7-day existing cholecystitis; factors predictive for concomitant common bile duct stones; strategies following gallbladder drainage. Multivariable analysis and propensity score matching will be used when appropriate for the etiological study aims. The TRIPOD guideline for prediction modelling will be used for the predictive study aims. Hospitals will receive their own results, set out against the national average and best practices, thereafter subsequent changes in hospital practice will be recorded. Conclusion: This study will determine the variation in treatment of cholecystitis in the Netherlands and its impact on clinical outcome. Its results will serve as an important incentive to create optimal, uniform cholecystitis treatment in the Netherlands.

Conditions

Timeline

Start date
2024-04-01
Primary completion
2025-06-30
Completion
2025-10-30
First posted
2024-04-05
Last updated
2024-08-12

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06349863. Inclusion in this directory is not an endorsement.